151 related articles for article (PubMed ID: 28636798)
1. A cCPE-based xenon biosensor for magnetic resonance imaging of claudin-expressing cells.
Piontek A; Witte C; May Rose H; Eichner M; Protze J; Krause G; Piontek J; Schröder L
Ann N Y Acad Sci; 2017 Jun; 1397(1):195-208. PubMed ID: 28636798
[TBL] [Abstract][Full Text] [Related]
2. Targeting claudin-overexpressing thyroid and lung cancer by modified Clostridium perfringens enterotoxin.
Piontek A; Eichner M; Zwanziger D; Beier LS; Protze J; Walther W; Theurer S; Schmid KW; Führer-Sakel D; Piontek J; Krause G
Mol Oncol; 2020 Feb; 14(2):261-276. PubMed ID: 31825142
[TBL] [Abstract][Full Text] [Related]
3. Specific binding of Clostridium perfringens enterotoxin fragment to Claudin-b and modulation of zebrafish epidermal barrier.
Zhang J; Ni C; Yang Z; Piontek A; Chen H; Wang S; Fan Y; Qin Z; Piontek J
Exp Dermatol; 2015 Aug; 24(8):605-10. PubMed ID: 25869230
[TBL] [Abstract][Full Text] [Related]
4. Reversible opening of the blood-brain barrier by claudin-5-binding variants of Clostridium perfringens enterotoxin's claudin-binding domain.
Neuhaus W; Piontek A; Protze J; Eichner M; Mahringer A; Subileau EA; Lee IM; Schulzke JD; Krause G; Piontek J
Biomaterials; 2018 Apr; 161():129-143. PubMed ID: 29421550
[TBL] [Abstract][Full Text] [Related]
5. Radiolabeled cCPE Peptides for SPECT Imaging of Claudin-4 Overexpression in Pancreatic Cancer.
Torres JB; Mosley M; Koustoulidou S; Hopkins S; Knapp S; Chaikuad A; Kondoh M; Tachibana K; Kersemans V; Cornelissen B
J Nucl Med; 2020 Dec; 61(12):1756-1763. PubMed ID: 32414951
[TBL] [Abstract][Full Text] [Related]
6. Directed structural modification of Clostridium perfringens enterotoxin to enhance binding to claudin-5.
Protze J; Eichner M; Piontek A; Dinter S; Rossa J; Blecharz KG; Vajkoczy P; Piontek J; Krause G
Cell Mol Life Sci; 2015 Apr; 72(7):1417-32. PubMed ID: 25342221
[TBL] [Abstract][Full Text] [Related]
7. Development, structure, and mechanism of synthetic antibodies that target claudin and Clostridium perfringens enterotoxin complexes.
Orlando BJ; Dominik PK; Roy S; Ogbu CP; Erramilli SK; Kossiakoff AA; Vecchio AJ
J Biol Chem; 2022 Sep; 298(9):102357. PubMed ID: 35952760
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of Clostridium perfringens enterotoxin interaction with claudin-3/-4 protein suggests structural modifications of the toxin to target specific claudins.
Veshnyakova A; Piontek J; Protze J; Waziri N; Heise I; Krause G
J Biol Chem; 2012 Jan; 287(3):1698-708. PubMed ID: 22128179
[TBL] [Abstract][Full Text] [Related]
9. Claudin-4 SPECT Imaging Allows Detection of Aplastic Lesions in a Mouse Model of Breast Cancer.
Mosley M; Knight J; Neesse A; Michl P; Iezzi M; Kersemans V; Cornelissen B
J Nucl Med; 2015 May; 56(5):745-51. PubMed ID: 25840973
[TBL] [Abstract][Full Text] [Related]
10. Structural basis for
Vecchio AJ; Rathnayake SS; Stroud RM
Proc Natl Acad Sci U S A; 2021 Apr; 118(15):. PubMed ID: 33876770
[TBL] [Abstract][Full Text] [Related]
11. Use of Modified
Beier LS; Rossa J; Woodhouse S; Bergmann S; Kramer HB; Protze J; Eichner M; Piontek A; Vidal-Y-Sy S; Brandner JM; Krause G; Zitzmann N; Piontek J
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561440
[TBL] [Abstract][Full Text] [Related]
12. Dendronized cryptophanes as water-soluble xenon hosts for (129)Xe magnetic resonance imaging.
Tyagi R; Witte C; Haag R; Schröder L
Org Lett; 2014 Sep; 16(17):4436-9. PubMed ID: 25152959
[TBL] [Abstract][Full Text] [Related]
13. Claudins overexpression in ovarian cancer: potential targets for Clostridium Perfringens Enterotoxin (CPE) based diagnosis and therapy.
English DP; Santin AD
Int J Mol Sci; 2013 May; 14(5):10412-37. PubMed ID: 23685873
[TBL] [Abstract][Full Text] [Related]
14. A claudin 3 and claudin 4-targeted Clostridium perfringens protoxin is selectively cytotoxic to PSA-producing prostate cancer cells.
Romanov V; Whyard TC; Waltzer WC; Gabig TG
Cancer Lett; 2014 Sep; 351(2):260-4. PubMed ID: 24952257
[TBL] [Abstract][Full Text] [Related]
15. Claudin targeting as an effective tool for directed barrier modulation of the viable epidermis.
Beier LS; Waldow A; Khomeijani Farahani S; Mannweiler R; Vidal-Y-Sy S; Brandner JM; Piontek J; Günzel D
Ann N Y Acad Sci; 2022 Nov; 1517(1):251-265. PubMed ID: 35994210
[TBL] [Abstract][Full Text] [Related]
16. Potential roles of claudin-3 and claudin-4 in ovarian cancer management.
Uthayanan L; El-Bahrawy M
J Egypt Natl Canc Inst; 2022 Jun; 34(1):24. PubMed ID: 35665865
[TBL] [Abstract][Full Text] [Related]
17. On the interaction of Clostridium perfringens enterotoxin with claudins.
Veshnyakova A; Protze J; Rossa J; Blasig IE; Krause G; Piontek J
Toxins (Basel); 2010 Jun; 2(6):1336-56. PubMed ID: 22069641
[TBL] [Abstract][Full Text] [Related]
18. Claudin-3 and claudin-4 regulate sensitivity to cisplatin by controlling expression of the copper and cisplatin influx transporter CTR1.
Shang X; Lin X; Manorek G; Howell SB
Mol Pharmacol; 2013 Jan; 83(1):85-94. PubMed ID: 23053666
[TBL] [Abstract][Full Text] [Related]
19. Optimization of xenon biosensors for detection of protein interactions.
Lowery TJ; Garcia S; Chavez L; Ruiz EJ; Wu T; Brotin T; Dutasta JP; King DS; Schultz PG; Pines A; Wemmer DE
Chembiochem; 2006 Jan; 7(1):65-73. PubMed ID: 16342304
[TBL] [Abstract][Full Text] [Related]
20. An Expanded Palette of Xenon-129 NMR Biosensors.
Wang Y; Dmochowski IJ
Acc Chem Res; 2016 Oct; 49(10):2179-2187. PubMed ID: 27643815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
